Anika Therapeutics Inc ANIK

Healthcare Biotechnology

Anika Therapeutics, Inc. is a global joint preservation company. The Company creates and delivers advancements in early intervention orthopedic care, including in the areas of osteoarthritis (OA) pain management, regenerative solutions, and sports medicine. It is focused on developing, manufacturing and commercializing products on its hyaluronic acid (HA), technology platform. Its OA Pain Management product family consists of Monovisc and Orthovisc, its injectable, HA, OA Pain Management offerings are indicated to provide pain relief from osteoarthritis conditions; and Cingal, its novel, next generation, single-injection OA Pain Management product consisting of its proprietary cross-linked HA material combined with a steroid. Its Joint Preservation and Restoration product family consists of its portfolio of orthopedic regenerative solutions products utilizing HA, including Integrity, its new hyaluronic acid-based scaffold for rotator cuff and other tendon repairs.

NDAQ:ANIK - Post by User

Anika Therapeutics Inc

<< Previous

Bullboard Posts

Post by whytestockson May 09, 2024 11:00pm

45 Views

Post# 36032738

(ANIK) Investment Analysis

BREAKING NEWS: $ANIK (ANIK) Investment Analysis2024-05-09 04:02:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...ANIK - (ANIK) Investment Analysis

<< Previous

Bullboard Posts

AI companies to invest in